Intrinsiqq
Serina Therapeutics Inc. logo

Serina Therapeutics Inc. Insider Trading

SER

⊜ Compare
Last 12 months

Insiders bought 78K and sold 401K on the open market.

All of the selling was scheduled in advance under 10b5-1 plans.

Net open-market
−323K
5 buys · 20 sales
Under a 10b5-1 plan
100%
of the value sold
Insiders who bought / sold
4 / 1
executives and directors
Last open-market buy
Jul 2026
Jul 7, 2026

Get an email when SER's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Jul 7
    Stephen K. Brannan
    Director · bought 1,000 at $2.03
    2K
    New position
  • Jun 11 – 12
    Karen J Wilson
    Director · bought 10,100 at avg $1.76
    18K
    New position
  • May 22
    Jay Venkatesan
    Director · bought 589 at $1.78
    1K
    0.3% of stake
  • May 21 – 22
    Karen J Wilson
    Director · bought 20,000 at avg $1.85
    37K
    New position
  • May 19
    Richard Peter Marshall
    Director · bought 12,183 at $1.65
    20K
    New position
  • Mar 2310b5-1 plan
    Randall Moreadith
    Chief Scientific Officer · sold 6,500 at $2.86
    19K
    100% of stake
  • Mar 1910b5-1 plan
    Randall Moreadith
    Chief Scientific Officer · sold 39,000 at $2.50
    98K
    100% of stake
  • Feb 210b5-1 plan
    Randall Moreadith
    Chief Scientific Officer · sold 6,500 at $3.03
    20K
    100% of stake
  • Jan 2810b5-1 plan
    Randall Moreadith
    Chief Scientific Officer · sold 6,500 at $3.57
    23K
    100% of stake
  • Jan 2210b5-1 plan
    Randall Moreadith
    Chief Scientific Officer · sold 2,500 at $2.95
    7K
    100% of stake
  • Jan 20 – 2110b5-1 plan
    Randall Moreadith
    Chief Scientific Officer · sold 4,000 at avg $3.04
    12K
    100% of stake
  • Jan 13 – 1410b5-1 plan
    Randall Moreadith
    Chief Scientific Officer · sold 6,500 at avg $2.50
    16K
    100% of stake
  • Jan 810b5-1 plan
    Randall Moreadith
    Chief Scientific Officer · sold 13,000 at $2.69
    35K
    100% of stake
  • Dec 23, 202510b5-1 plan
    Randall Moreadith
    Chief Scientific Officer · sold 4,100 at $2.60
    11K
    100% of stake
  • Dec 22, 202510b5-1 plan
    Randall Moreadith
    Chief Scientific Officer · sold 5,673 at $2.67
    15K
    100% of stake
  • Dec 16, 202510b5-1 plan
    Randall Moreadith
    Chief Scientific Officer · sold 3,227 at $2.96
    10K
    100% of stake
  • Dec 12, 202510b5-1 plan
    Randall Moreadith
    Chief Scientific Officer · sold 1,700 at $3.26
    6K
    100% of stake
  • Dec 11, 202510b5-1 plan
    Randall Moreadith
    Chief Scientific Officer · sold 3,555 at $3.24
    12K
    100% of stake
  • Dec 9, 2025 – Dec 10, 202510b5-1 plan
    Randall Moreadith
    Chief Scientific Officer · sold 1,245 at avg $3.33
    4K
    100% of stake
  • Dec 2, 2025 – Dec 3, 202510b5-1 plan
    Randall Moreadith
    Chief Scientific Officer · sold 6,500 at avg $3.61
    23K
    100% of stake
  • Nov 25, 202510b5-1 plan
    Randall Moreadith
    Chief Scientific Officer · sold 5,965 at $3.90
    23K
    50% of stake
  • Nov 24, 202510b5-1 plan
    Randall Moreadith
    Chief Scientific Officer · sold 535 at $3.94
    2K
    100% of stake
  • Nov 18, 202510b5-1 plan
    Randall Moreadith
    Chief Scientific Officer · sold 6,500 at $3.75
    24K
    100% of stake
  • Nov 10, 202510b5-1 plan
    Randall Moreadith
    Chief Scientific Officer · sold 6,500 at $4.10
    27K
    100% of stake
  • Nov 5, 202510b5-1 plan
    Randall Moreadith
    Chief Scientific Officer · sold 3,398 at $4.24
    14K
    100% of stake
  • Nov 4, 202510b5-1 plan
    Randall Moreadith
    Chief Scientific Officer · sold 3,102 at $4.40
    14K
    100% of stake
  • Oct 28, 202510b5-1 plan
    Randall Moreadith
    Chief Scientific Officer · sold 5,551 at $4.96
    28K
    100% of stake
  • Oct 27, 202510b5-1 plan
    Randall Moreadith
    Chief Scientific Officer · sold 949 at $5.19
    5K
    100% of stake
  • Oct 20, 202510b5-1 plan
    Randall Moreadith
    Chief Scientific Officer · sold 6,500 at $4.97
    32K
    100% of stake
  • Oct 13, 202510b5-1 plan
    Randall Moreadith
    Chief Scientific Officer · sold 4,326 at $5.20
    22K
    100% of stake
  • Aug 25, 2025 – Aug 26, 202510b5-1 plan
    Randall Moreadith
    Chief Scientific Officer · sold 47,674 at avg $6.95
    331K
    100% of stake
  • Aug 18, 2025 – Aug 20, 202510b5-1 plan
    Randall Moreadith
    Chief Scientific Officer · sold 4,304 at avg $5.18
    22K
    100% of stake
  • Aug 12, 202510b5-1 plan
    Randall Moreadith
    Chief Scientific Officer · sold 5,500 at $5.25
    29K
    100% of stake
  • Aug 4, 202510b5-1 plan
    Randall Moreadith
    Chief Scientific Officer · sold 5,500 at $5.17
    28K
    100% of stake
  • Jul 29, 202510b5-1 plan
    Randall Moreadith
    Chief Scientific Officer · sold 4,196 at $6.50
    27K
    100% of stake
  • Jul 28, 2025No plan
    Randall Moreadith
    Chief Scientific Officer · sold 6,500 at $5.89
    38K
    100% of stake
  • Jul 21, 2025No plan
    Randall Moreadith
    Chief Scientific Officer · sold 6,500 at $5.34
    35K
    100% of stake
  • Jul 14, 2025No plan
    Randall Moreadith
    Chief Scientific Officer · sold 6,500 at $5.01
    33K
    100% of stake
  • Jul 7, 202510b5-1 plan
    Randall Moreadith
    Chief Scientific Officer · sold 6,500 at $5.67
    37K
    100% of stake
  • Jun 30, 202510b5-1 plan
    Randall Moreadith
    Chief Scientific Officer · sold 6,500 at $5.78
    38K
    100% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch SER, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with SER

CompareIntrinsic value
HINDVyome Holdings, Inc
$1.74-1.92%20
SNGXSoligenix Inc.
$0.35-2.56%10
BFRGBullfrog AI Holdings Inc.
$0.53+0.57%40
IBIOiBio, Inc.
$0.80-2.44%10
LSTALisata Therapeutics Inc.
$1.06-2.75%10
AXIMAxim Biotechnologies Inc.
$0.00+6.67%0
PLPLPlandai Biotechnology Inc.
$0.00+0.00%30
ATNMActinium Pharmaceuticals Inc.
$1.41+0.71%30

Spot a number that looks wrong? Check it in SER's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing SER

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.